Results 261 to 270 of about 483,611 (352)

Value of clinical review for AI-guided deep vein thrombosis diagnosis with ultrasound imaging by non-expert operators. [PDF]

NPJ Digit Med
Speranza G, Mischkewitz S, Al-Noor F, Kainz B.   +3 more
europepmc   +1 more source

Shareholder-Value-Management [PDF]

, 1995
openaire   +2 more sources

Predicting Danish EQ-5D-5L Utilities Based on United Kingdom EQ-5D-3L Utilities for Use in Health Economic Models. [PDF]

Pharmacoecon Open
Torkilseng EB, Clarke N, Sopina L, Oddershede L, Wolf RT, Lawrance R, Trigg A, Bennett B, Shaw JW.   +8 more
europepmc   +1 more source

A Phase 1C, Open Label, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of DM199 Administered Intravenously with a Polyvinyl Chloride Bag in Adult Healthy Subjects and Adults Recently Taking Angiotensin‐Converting Enzyme Inhibitors

Clinical Pharmacology in Drug Development, EarlyView.
Abstract This small phase 1C, open‐label, single ascending dose study evaluated the safety, tolerability, and pharmacokinetics (PKs) of DM199, a recombinant form of human tissue kallikrein‐1 (KLK1). A small sample size of both healthy subjects and hypertensive adults recently taking angiotensin‐converting enzyme inhibitors was studied. KLK1 has a known
Michael Giuffre, Annette D. Lista, Nick Paulson, Lorianne Masuoka   +3 more
wiley   +1 more source

Cyclin E1/CDK2 activation defines a key vulnerability to WEE1 kinase inhibition in gynecological cancers. [PDF]

NPJ Precis Oncol
Kim D, Chung H, Liu W, Jeong K, Ozmen TY, Ozmen F, Rames MJ, Kim S, Guo X, Jameson N, de Jong PR, Yea S, Harford L, Li J, Mathews CA, Doroshow DB, Charles VJ, Kim D, Fischer K, Samatar AA, Jubb A, Bunker KD, Blackwell K, Simpkins F, Meric-Bernstam F, Mills GB, Harismendy O, Ma J, Lackner MR.   +28 more
europepmc   +1 more source

Can Fundamental Analysis Support Shareholder Value In A Transitional Market? Perspectives From Egypt

, 2011
Tarek Ibrahim Eldomiaty
openalex   +2 more sources

Improved Prediction of CYP2D6 Catalyzed Drug Metabolism by Taking Variant Substrate Specificities and Novel Polymorphic Haplotypes into Account

Clinical Pharmacology &Therapeutics, EarlyView.
The polymorphic CYP2D6 enzyme plays a pivotal role in the metabolism of approximately 25% of clinically prescribed drugs. However, the impact of specific genetic variants on the interindividual variability in CYP2D6‐mediated drug metabolism remains insufficiently quantified. This translational study sought to address this gap by analyzing the genotypes
Inger Johansson, Emmanouella M. Xanthopoulou, Yitian Zhou, Anabel Sanchez‐Spitman, Maaike van der Lee, Birgit M. Wollmann, Elisabet Størset, Jesse J. Swen, Henk‐Jan Guchelaar, Espen Molden, Marin M. Jukic, Magnus Ingelman‐Sundberg   +11 more
wiley   +1 more source

Centralized allocation of decision rights and enterprise transformation and upgrading: Based on human capital level and capital allocation efficiency. [PDF]

PLoS One
Tang Q, Sun H.
europepmc   +1 more source

Do Romanian Banking Institutions Create Shareholder Value?

, 2012
Anca Munteanu, Petre Brezeanu
openalex   +1 more source

Board Characteristics and Stakeholder Engagement and ESG Performance: The Relevance of European Gender Parity

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT The main goal of this study is to explore the effect of country‐level gender parity with a board characteristics and stakeholder engagement on ESG performance in sustainable companies. The sample comprises 940 sustainable international sustainable firm‐year observations from the following 13 countries: Denmark, Finland, France, Germany ...
Alfredo Grau‐Grau, Manuel Branco, Inmaculada Bel‐Oms   +2 more
wiley   +1 more source